Isolation and propagation of a human CD133- colon tumor-derived cell line with tumorigenic and angiogenic properties

Cell Transplantation

Volumn 19, Issue 6-7, 2010, Pages 865-877

  Navarro Alvarez, Nalú ^a,e   Kondo, Eisaku ^a   Kawamoto, Hironobu ^a   Hassan, Wael ^a   Yuasa, Takeshi ^a   Kubota, Yasuhiro ^a   Seita, Masayuki ^a   Nakahara, Hiroyuki ^a   Hayashi, Takahiro ^a   Nishikawa, Yuriko ^a   Hassan, Reham A R A ^a   Javed, Shahid M ^a   Noguchi, Hirofumi ^b   Matsumoto, Shinichi ^b   Nakaji, Shuhei ^c   Tanaka, Noriaki ^a   Kobayashi, Naoya ^a   Soto Gutierrez, Alejandro ^a,d  

^a OKAYAMA UNIVERSITY   (Japan)

^b BAYLOR RESEARCH INSTITUTE   (United States)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^d MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Cancer; Cell line; Cytokines; Gene expression; Intraperitoneal dissemination; Metastasis

Indexed keywords

BMI1 PROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD133 ANTIGEN; CD44V ANTIGEN; CELL SURFACE MARKER; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NANOG;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL ISOLATION; COLORECTAL CANCER; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

ADULT; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; COLONIC NEOPLASMS; CYTOKINES; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PEPTIDES; PHENOTYPE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 77958537327     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X508997     Document Type: Article

References (49)

1. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100(7):3983-3988; 2003.
2. Bai, Y. Q.; Miyake, S.; Iwai, T.; Yuasa, Y. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22(39):7942-7949; 2003.
3. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760; 2006.
4. Cao, R.; Tsukada, Y.; Zhang, Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20(6):845-854; 2005.
5. Chen, Y. C.; Hsu, H. S.; Chen, Y. W.; Tsai, T. H.; How, C. K.; Wang, C. Y.; Hung, S. C.; Chang, Y. L.; Tsai, M. L.; Lee, Y. Y.; Ku, H. H.; Chiou, S. H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3(7):e2637; 2008.
6. Chu, P.; Wu, E.; Weiss, L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod. Pathol. 13(9):962-972; 2000.
7. Clarke, M. F.; Dick, J. E.; Dirks, P. B.; Eaves, C. J.; Jamieson, C. H.; Jones, D. L.; Visvader, J.; Weissman, I. L.; Wahl, G. M. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66(19):9339-9344; 2006.
8. Collins, A. T.; Berry, P. A.; Hyde, C.; Stower, M. J.; Maitland, N. J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65(23):10946-10951; 2005.
9. Ducreux, M.; Raoul, J. L.; Marti, P.; Merrouche, Y.; Tigaud, J. M.; Rebischung, C.; Boige, V. High-dose irinotecan plus LV5FU2 or simplified LV5FU (HD-FOLFIRI) for patients with untreated metastatic colorectal cancer: A new way to allow resection of liver metastases? Oncology 74(1-2):17-24; 2008.
10. Ee, H. C.; Erler, T.; Bhathal, P. S.; Young, G. P.; James, R. J. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am. J. Pathol. 147(3):586-592; 1995.
11. Fernandes, A. M.; Meletti, T.; Guimaraes, R.; Stelling, M. P.; Marinho, P. A.; Valladao, A. S.; Rehen, S. K. Worldwide survey of published procedures to culture human embryonic stem cells. Cell Transplant. 19(5):509-523; 2010.
12. Fidler, I. J.; Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79(2):185-188; 1994.
13. Heppner, G. H.; Miller, F. R. The cellular basis of tumor progression. Int. Rev. Cytol. 177:1-56; 1998.
14. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J. W.; Guba, M.; Bruns, C. J.; Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3):313-323; 2007.
15. Hernandez, B. Y.; Frierson, H. F.; Moskaluk, C. A.; Li, Y. J.; Clegg, L.; Cote, T. R.; McCusker, M. E.; Hankey, B. F.; Edwards, B. K.; Goodman, M. T. CK20 and CK7 protein expression in colorectal cancer: Demonstration of the utility of a population-based tissue microarray. Hum. Pathol. 36(3):275-281; 2005.
16. Hinoi, T.; Tani, M.; Lucas, P. C.; Caca, K.; Dunn, R. L.; Macri, E.; Loda, M.; Appelman, H. D.; Cho, K. R.; Fearon, E. R. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am. J. Pathol. 159(6):2239-2248; 2001.
17. Jacobs, J. J.; Scheijen, B.; Voncken, J. W.; Kieboom, K.; Berns, A.; van Lohuizen, M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13(20):2678-2690; 1999.
18. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Smigal, C.; Thun, M. J. Cancer statistics, 2006. CA Cancer J. Clin. 56(2):106-130; 2006.
19. Jordan, C. T.; Guzman, M. L.; Noble, M. Cancer stem cells. N. Engl. J. Med. 355(12):1253-1261; 2006.
20. Kaimaktchiev, V.; Terracciano, L.; Tornillo, L.; Spichtin, H.; Stoios, D.; Bundi, M.; Korcheva, V.; Mirlacher, M.; Loda, M.; Sauter, G.; Corless, C. L. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod. Pathol. 17(11):1392-1399; 2004.
21. Khan, O. A.; Ranson, M.; Michael, M.; Olver, I.; Levitt, N. C.; Mortimer, P.; Watson, A. J.; Margison, G. P.; Midgley, R.; Middleton, M. R. A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. Br. J. Cancer 98(10):1614-1618; 2008.
22. Kim, C. F.; Jackson, E. L.; Woolfenden, A. E.; Lawrence, S.; Babar, I.; Vogel, S.; Crowley, D.; Bronson, R. T.; Jacks, T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6):823-835; 2005.
23. Kim, J. H.; Yoon, S. Y.; Kim, C. N.; Joo, J. H.; Moon, S. K.; Choe, I. S.; Choe, Y. K.; Kim, J. W. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 203(2):217-224; 2004.
24. Kobayashi, N.; Navarro-Alvarez, N.; Soto-Gutierrez, A.; Kawamoto, H.; Kondo, Y.; Yamatsuji, T.; Shirakawa, Y.; Naomoto, Y.; Tanaka, N. Cancer stem cell research: Current situation and problems. Cell Transplant. 17(1-2):19-25; 2008.
25. Lash, R. H.; Hart, W. R. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am. J. Surg. Pathol. 11(2):114-121; 1987.
26. Lessard, J.; Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423(6937):255-260; 2003.
27. Mallo, G. V.; Rechreche, H.; Frigerio, J. M.; Rocha, D.; Zweibaum, A.; Lacasa, M.; Jordan, B. R.; Dusetti, N. J.; Dagorn, J. C.; Iovanna, J. L. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int. J. Cancer 74(1):35-44; 1997.
28. Menendez, M.; Gonzalez, S.; Obrador-Hevia, A.; Dominguez, A.; Pujol, M. J.; Valls, J.; Canela, N.; Blanco, I.; Torres, A.; Pineda-Lucena, A.; Moreno, V.; Bachs, O.; Capella, G. Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis. Gastroenterology 134(1):56-64; 2008.
29. Mueller, M. M.; Fusenig, N. E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4(11):839-849; 2004.
30. Navarro-Alvarez, N.; Soto-Gutierrez, A.; Yuasa, T.; Yamatsuji, T.; Shirakawa, Y.; Nagasaka, T.; Sun, S. D.; Javed, M. S.; Tanaka, N.; Kobayashi, N. Long-term culture of Japanese human embryonic stem cells in feeder-free conditions. Cell Transplant. 17(1-2):27-33; 2008.
31. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110; 2007.
32. Park, I. K.; Qian, D.; Kiel, M.; Becker, M. W.; Pihalja, M.; Weissman, I. L.; Morrison, S. J.; Clarke, M. F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423(6937):302-305; 2003.
33. Phillips, T. M.; McBride, W. H.; Pajonk, F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 98(24):1777-1785; 2006.
34. Ricci-Vitiani, L.; Lombardi, D. G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R. Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115; 2007.
35. Ricci-Vitiani, L.; Pagliuca, A.; Palio, E.; Zeuner, A.; De Maria, R. Colon cancer stem cells. Gut 57(4):538-548; 2008.
36. Shmelkov, S. V.; Butler, J. M.; Hooper, A. T.; Hormigo, A.; Kushner, J.; Milde, T.; St. Clair, R.; Baljevic, M.; White, I.; Jin, D. K.; Chadburn, A.; Murphy, A. J.; Valenzuela, D. M.; Gale, N. W.; Thurston, G.; Yancopoulos, G. D.; D'Angelica, M.; Kemeny, N.; Lyden, D.; Rafii, S. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118(6):2111-2120; 2008.
37. Silberg, D. G.; Swain, G. P.; Suh, E. R.; Traber, P. G. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 119(4):961-971; 2000.
38. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature 432(7015):396-401; 2004.
39. Stacker, S. A.; Caesar, C.; Baldwin, M. E.; Thornton, G. E.; Williams, R. A.; Prevo, R.; Jackson, D. G.; Nishikawa, S.; Kubo, H.; Achen, M. G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7(2):186-191; 2001.
40. Tanaka, M.; Jin, G.; Yamazaki, Y.; Takahara, T.; Takuwa, M.; Nakamura, T. Identification of candidate cooperative genes of the Apc mutation in transformation of the colon epithelial cell by retroviral insertional mutagenesis. Cancer Sci. 99(5):979-985; 2008.
41. Vang, R.; Gown, A. M.; Wu, L. S.; Barry, T. S.; Wheeler, D. T.; Yemelyanova, A.; Seidman, J. D.; Ronnett, B. M. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: Comparison with CK20 and correlation with coordinate expression of CK7. Mod. Pathol. 19(11):1421-1428; 2006.
42. Vincenzi, B.; Santini, D.; Galluzzo, S.; Russo, A.; Fulfaro, F.; Silletta, M.; Battistoni, F.; Rocci, L.; Zobel, B. B.; Adamo, V.; Dicuonzo, G.; Tonini, G. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin. Cancer Res. 14(13):4219-4224; 2008.
43. Vonlanthen, S.; Heighway, J.; Altermatt, H. J.; Gugger, M.; Kappeler, A.; Borner, M. M.; van Lohuizen, M.; Betticher, D. C. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84(10):1372-1376; 2001.
44. Voronov, E.; Shouval, D. S.; Krelin, Y.; Cagnano, E.; Benharroch, D.; Iwakura, Y.; Dinarello, C. A.; Apte, R. N. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100(5):2645-2650; 2003.
45. Wang, J.; Sakariassen, P. O.; Tsinkalovsky, O.; Immervoll, H.; Boe, S. O.; Svendsen, A.; Prestegarden, L.; Rosland, G.; Thorsen, F.; Stuhr, L.; Molven, A.; Bjerkvig, R.; Enger, P. O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122(4):761-768; 2008.
46. Werling, R. W.; Yaziji, H.; Bacchi, C. E.; Gown, A. M. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas. Am. J. Surg. Pathol. 27(3):303-310; 2003.
47. Young, R. H.; Scully, R. E. Metastatic tumors in the ovary: A problem-oriented approach and review of the recent literature. Semin. Diagn. Pathol. 8(4):250-276; 1991.
48. Zhang, P. J.; Shah, M.; Spiegel, G. W.; Brooks, J. J. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl. Immunohistochem. Mol. Morphol. 11(4):306-310; 2003.
49. Zito, G.; Richiusa, P.; Bommarito, A.; Carissimi, E.; Russo, L.; Coppola, A.; Zerilli, M.; Rodolico, V.; Criscimanna, A.; Amato, M.; Pizzolanti, G.; Galluzzo, A.; Giordano, C. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS ONE 3(10):e3544; 2008.